CPRX FY 2010 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$488,958

Gross Profit

$488,958100.0% margin

Operating Income

-$4M-823.0% margin

Net Income

-$4M-819.4% margin

EPS (Diluted)

$-0.22

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$450,089

Balance Sheet

Total Assets

$6M

Total Liabilities

$313,709

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$488,958	$0	—
Gross Profit	$488,958	$0	—
Operating Income	-$4M	-$7M	+44.7%
Net Income	-$4M	-$7M	+44.7%